This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Oct 2010

Hameln Pharma Extends Its Portfolio

Specialist for sterile liquids is now also offering WFI and buffered solutions

hameln pharma, specialist for contract manufacturing of parenteral solutions and suspensions, has expanded its portfolio and is also offering Water for Injection (WFI) as well as buffered solutions, both filled into bags and usable for various processes in the pharmaceutical industry.

Hameln / Paris, 05. October 2010. Manufactured in a sterile production plant which is certified according to cGMP and regularly audited by the US-American FDA WFI and buffered solutions by hameln pharma are suitable for the development and production of biotechnological and chemical API. Due to their high quality they can also be used in clinical studies and for commercial batches.

“All solutions are handled under clean room class C conditions or higher”, explains Dr. Olaf Schrake, Sales Director hameln pharma. “Using standard filters the solutions are filled into multi-layer bags via manifold. This means that we can offer different bag sizes from
one and the same batch”.

Apart from certain standard solutions such as NaCI, PBS (Phosphate Buffered Saline) or phosphate buffer hameln pharma also offers customised solutions, manufactured according to the individual specifications o

Related News